ARTICLES

Design, Synthesis of Pentacyclic Triterpenoid Glucose Conjugate and in vitro Activity against Influenza Virus

  • Ming Cai ,
  • Liang Shao ,
  • Fan Yang ,
  • Jihong Zhang ,
  • Fei Yu
Expand
  • a Medical Faculty, Kunming University of Science and Technology, Kunming 650500
    b State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191
*Corresponding author. E-mail:

Received date: 2021-11-03

  Revised date: 2021-12-31

  Online published: 2022-01-27

Supported by

National Natural Science Foundation of China(22167018); Foundation of State Key Laboratory of Natural and Biomimetic Drugs(K202003); Yunnan Fundamental Research Projects(2019FB125); Yunnan Fundamental Research Projects(2018FB145)

Abstract

Previous studies have revealed that oleanolic acid (OA) C28-glucose conjugate displayed potent anti-influenza viral activity in vitro. However, the effect of pentacyclic triterpene scaffold coupled with glucose on anti-influenza virus activity has not been clarified. Herein, as a continuous further study, a series of pentacyclic triterpene-glucose conjugates were prepared via CuAAC reaction, and the anti-influenza activity of these compounds was evaluated in vitro. Among them, compound 4d, an betulinic acid (BA)-glucose conjugate, showed potent anti-influenza virus activity (IC50 value of 9.09 μmol/L), and no obvious cytotoxic effect on MDCK (Madin-Darbey Canine Kidney) cells was observed (CC50>100 μmol/L). Structure-activity relationship studies showed that both triterpene scaffolds and glucose moiety have important effects on the anti-viral activity. Overall, this finding further extends the utility of triterpene derivatives in anti-influenza virus drug design.

Cite this article

Ming Cai , Liang Shao , Fan Yang , Jihong Zhang , Fei Yu . Design, Synthesis of Pentacyclic Triterpenoid Glucose Conjugate and in vitro Activity against Influenza Virus[J]. Chinese Journal of Organic Chemistry, 2022 , 42(5) : 1453 -1462 . DOI: 10.6023/cjoc202111008

References

[1]
Li, H.; Li, M.; Xu, R.; Wang, S.; Zhang, Y.; Zhang, L.; Zhou, D.; Xiao, S. Eur. J. Med. Chem. 2019, 163, 560.
[2]
Chintakrindi, A. S.; Gohil, D. J.; Chowdhary, A. S.; Kanyalkar, M. A. Bioorg. Med. Chem. 2020, 28, 115191.
[3]
Cline, T. D.; Karlsson, E. A.; Seufzer, B. J.; Schultz-Cherry, S. J. Virol. 2013, 87, 1411.
[4]
Chintakrindi, A. S.; Gohil, D. J.; Kothari, S. T.; Chowdhary, A. S.; Kanyalkar, M. A. Med. Chem. Res. 2018, 27, 1013.
[5]
Naesens, L.; Stevaert, A.; Vanderlinden, E. Curr. Opin. Pharmacol. 2016, 30, 106.
[6]
Lee, N.; Hurt, A. C. Curr. Opin. Infect. Dis. 2018, 31, 520.
[7]
Yen, H. L.; Hoffmann, E.; Taylor, G.; Scholtissek, C.; Monto, A. S.; Webster, R. G.; Govorkova, E. A. J. Virol. 2006, 80, 8787.
[8]
Tian, Z.; Si, L.; Meng, K.; Meng, K.; Zhou, X.; Zhang, Y.; Zhou, D.; Xiao, S. Eur. J. Med. Chem. 2017, 134, 133.
[9]
Yu, M.; Si, L.; Wang, Y.; Wu, Y.; Yu, F.; Jiao, P.; Shi, Y.; Wang, H.; Xiao, S.; Fu, G.; Tian, K.; Wang, Y.; Guo, Z.; Ye, X.; Zhang, L.; Zhou, D. J. Med. Chem. 2014, 57, 10058.
[10]
Luo, M.; Wu, X.; Li, Y.; Guo, F. Molecules 2021, 26, 895.
[11]
Su, Y.; Meng, L.; Sun, J.; Li, W.; Shao, L.; Chen, K.; Zhou, D., Yang, F.; Yu, F. Eur. J. Med. Chem. 2019, 182, 111622.
[12]
Shao, L.; Yang, F.; Li, W. J.; Yu, F. Chin. J. Org. Chem. 2021, 41, 2454. (in Chinese)
[12]
(邵亮, 杨帆, 李维嘉, 俞飞, 有机化学, 2021, 41, 2454.)
[13]
Nouri-Felekori, M.; Nezafati, N.; Moraveji, M.; Hesaraki, S.; Ramezani, T. Int. J. Biol. Macromol. 2021, 183, 2030.
[14]
Agrahari, A. K.; Bose, P.; Jaiswal, M. K.; Rajkhowa, S.; Singh, A. S.; Hotha, S.; Mishra, N.; Tiwari, V. K. Chem. Rev. 2021, 121, 7638.
[15]
Devaraj, N. K.; Finn, M. G. Chem. Rev. 2021, 121, 6697.
[16]
Chen, D.; Zhang, P.; Sun, Y.; Wang, P.; Zhang, C.; Kong, L.; Zhang, J.; Sun, H.; Wen, X. Org. Biomol. Chem. 2016, 14, 11154.
[17]
Li, H.; Li, M.; Xu, R.; Wang, S.; Zhang, Y.; Zhang, L.; Zhou, D.; Xiao, S. Eur. J. Med. Chem. 2019, 163, 560.
[18]
Spackman, E.; Sitaras, I. Methods. Mol. Biol. 2020, 2123, 11.
Outlines

/